Cargando…

Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong

BACKGROUND: To describe the infection control strategy to achieve zero nosocomial transmission of symptomatic coronavirus disease (COVID-19) due to SARS-CoV-2 during the prepandemic phase (the first 72 days after announcement of pneumonia cases in Wuhan) in Hong Kong. METHODS: Administrative support...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Vincent C.C., Wong, Shuk-Ching, Chuang, Vivien W.M., So, Simon Y.C., Chen, Jonathan H.K., Sridhar, Siddharth, To, Kelvin K.W., Chan, Jasper F.W., Hung, Ivan F.N., Ho, Pak-Leung, Yuen, Kwok-Yung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246012/
https://www.ncbi.nlm.nih.gov/pubmed/32461068
http://dx.doi.org/10.1016/j.ajic.2020.05.018
_version_ 1783537865190277120
author Cheng, Vincent C.C.
Wong, Shuk-Ching
Chuang, Vivien W.M.
So, Simon Y.C.
Chen, Jonathan H.K.
Sridhar, Siddharth
To, Kelvin K.W.
Chan, Jasper F.W.
Hung, Ivan F.N.
Ho, Pak-Leung
Yuen, Kwok-Yung
author_facet Cheng, Vincent C.C.
Wong, Shuk-Ching
Chuang, Vivien W.M.
So, Simon Y.C.
Chen, Jonathan H.K.
Sridhar, Siddharth
To, Kelvin K.W.
Chan, Jasper F.W.
Hung, Ivan F.N.
Ho, Pak-Leung
Yuen, Kwok-Yung
author_sort Cheng, Vincent C.C.
collection PubMed
description BACKGROUND: To describe the infection control strategy to achieve zero nosocomial transmission of symptomatic coronavirus disease (COVID-19) due to SARS-CoV-2 during the prepandemic phase (the first 72 days after announcement of pneumonia cases in Wuhan) in Hong Kong. METHODS: Administrative support with the aim of zero nosocomial transmission by reducing elective clinical services, decanting wards, mobilizing isolation facilities, providing adequate personal protective equipment, coordinating laboratory network for rapid molecular diagnosis under 4-tier active surveillance for hospitalized patients and outpatients, and organizing staff forum and training was implemented under the framework of preparedness plan in Hospital Authority. The trend of SARS-CoV-2 in the first 72 days was compared with that of SARS-CoV 2003. RESULTS: Up to day 72 of the epidemic, 130 (0.40%) of 32,443 patients being screened confirmed to have SARS-CoV-2 by reverse transcription polymerase chain reaction. Compared with SARS outbreak in 2003, the SARS-CoV-2 case load constituted 8.9% (130 SARS-CoV-2/1458 SARS-CoV) of SARS-CoV infected cases at day 72 of the outbreak. The incidences of nosocomial acquisition of SARS-CoV per 1,000 SARS-patient-day and per 100 SARS-patient-admission were 7.9 and 16.9, respectively, which were significantly higher than the corresponding incidences of SARS-CoV-2 (zero infection, P <.001). CONCLUSIONS: Administrative support to infection control could minimize the risk of nosocomial transmission of SARS-CoV-2.
format Online
Article
Text
id pubmed-7246012
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72460122020-05-26 Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong Cheng, Vincent C.C. Wong, Shuk-Ching Chuang, Vivien W.M. So, Simon Y.C. Chen, Jonathan H.K. Sridhar, Siddharth To, Kelvin K.W. Chan, Jasper F.W. Hung, Ivan F.N. Ho, Pak-Leung Yuen, Kwok-Yung Am J Infect Control Major Article BACKGROUND: To describe the infection control strategy to achieve zero nosocomial transmission of symptomatic coronavirus disease (COVID-19) due to SARS-CoV-2 during the prepandemic phase (the first 72 days after announcement of pneumonia cases in Wuhan) in Hong Kong. METHODS: Administrative support with the aim of zero nosocomial transmission by reducing elective clinical services, decanting wards, mobilizing isolation facilities, providing adequate personal protective equipment, coordinating laboratory network for rapid molecular diagnosis under 4-tier active surveillance for hospitalized patients and outpatients, and organizing staff forum and training was implemented under the framework of preparedness plan in Hospital Authority. The trend of SARS-CoV-2 in the first 72 days was compared with that of SARS-CoV 2003. RESULTS: Up to day 72 of the epidemic, 130 (0.40%) of 32,443 patients being screened confirmed to have SARS-CoV-2 by reverse transcription polymerase chain reaction. Compared with SARS outbreak in 2003, the SARS-CoV-2 case load constituted 8.9% (130 SARS-CoV-2/1458 SARS-CoV) of SARS-CoV infected cases at day 72 of the outbreak. The incidences of nosocomial acquisition of SARS-CoV per 1,000 SARS-patient-day and per 100 SARS-patient-admission were 7.9 and 16.9, respectively, which were significantly higher than the corresponding incidences of SARS-CoV-2 (zero infection, P <.001). CONCLUSIONS: Administrative support to infection control could minimize the risk of nosocomial transmission of SARS-CoV-2. Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2020-08 2020-05-24 /pmc/articles/PMC7246012/ /pubmed/32461068 http://dx.doi.org/10.1016/j.ajic.2020.05.018 Text en © 2020 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Major Article
Cheng, Vincent C.C.
Wong, Shuk-Ching
Chuang, Vivien W.M.
So, Simon Y.C.
Chen, Jonathan H.K.
Sridhar, Siddharth
To, Kelvin K.W.
Chan, Jasper F.W.
Hung, Ivan F.N.
Ho, Pak-Leung
Yuen, Kwok-Yung
Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
title Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
title_full Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
title_fullStr Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
title_full_unstemmed Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
title_short Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
title_sort absence of nosocomial transmission of coronavirus disease 2019 (covid-19) due to sars-cov-2 in the prepandemic phase in hong kong
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246012/
https://www.ncbi.nlm.nih.gov/pubmed/32461068
http://dx.doi.org/10.1016/j.ajic.2020.05.018
work_keys_str_mv AT chengvincentcc absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT wongshukching absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT chuangvivienwm absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT sosimonyc absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT chenjonathanhk absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT sridharsiddharth absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT tokelvinkw absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT chanjasperfw absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT hungivanfn absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT hopakleung absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong
AT yuenkwokyung absenceofnosocomialtransmissionofcoronavirusdisease2019covid19duetosarscov2intheprepandemicphaseinhongkong